Overview

A Study of ZN-c3 in Combination With Gemcitabine in Subjects With Osteosarcoma

Status:
Recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
This is a phase 1/2 study of ZN-c3 in combination with gemcitabine in adult and pediatric subjects with relapsed or refractory osteosarcoma.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
K-Group Beta
Treatments:
Gemcitabine